Evolocumab A Breakthrough in Lipid-Lowering Therapy for Cardiovascular Risk Reduction Introduction Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality globally. Elevated low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for atherosclerosis and coronary artery disease. While statins have […]